Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)

Recruiting now

Conditions studied: Idiopathic Pulmonary Fibrosis

In brief

The purpose of the study is to identify genetic and biologic markers that may predict the loss of lung function due to idiopathic pulmonary fibrosis. The studies will compare genetic and biologic markers of samples to changes in symptoms. The ultimate goal is to predict if or when patients are likely to experience a rapid decline in lung function due to disease progression.

Key facts

Study ID

NCT00373841

Run by

University of Pittsburgh

People needed

500

Starts

2005-10-01

Expected to finish

2030-07-01

Last updated by the study team

2025-10-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who are 18 or older
• Diagnosis of Idiopathic Pulmonary Fibrosis
• Treated at the Simmons Center

You may not qualify if…

• Other Lung Illness

Where it is running

• Michelle F MacPherson — Pittsburgh, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.